Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

Why pay $100B for AstraZeneca? Let Pfizer's CEO count the reasons

28.04.2014 / Fierce Pharma

Pfizer considers itself a megamerger expert. And it's hoping to prove that with another megadeal–a $100-billion-or-so buyout of AstraZeneca. After last week's headlines about a possible buyout, both companies confirm that Pfizer is hot to trot and ready to parley.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: